Details of the Drug Therapeutic Target (DTT)

General Information of Drug Therapeutic Target (DTT) (ID: TTMDQIJ)

• DTT Name: Oxalate absorption (Oxalate absor)
• Gene Name: Oxalate absor
• DTT Type: Clinical trial target; [1]
• UniProt ID: NOUNIPROTAC
• TTD ID: T04977

Molecular Interaction Atlas (MIA) of This DTT

1 Clinical Trial Drug(s) Targeting This DTT

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
Reloxaliase	DMOWINT	Hyperoxaluria	5C51.2	Phase 3	[2]

1 Discontinued Drug(s) Targeting This DTT

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
ALTU-237	DMS5C06	Hyperoxaluria	5C51.2	Discontinued in Phase 1	[1]

References

• [1] Hyperoxaluria: a gut-kidney axis. Kidney Int. 2011 Dec;80(11):1146-58.
• [2] Clinical pipeline report, company report or official report of Allena Pharmaceuticals.